M & A Law Prof Blog

Editor: Brian JM Quinn
Boston College Law School

Monday, January 31, 2011

Genzyme deal reached?

So says Reuters

U.S. biotech company Genzyme Corp and French drugmaker Sanofi-Aventis SA have reached an agreement in principle on the outlines of a merger deal, three sources familiar with the situation said on Monday.

The agreement in principle would include a so-called contingent value right (CVR), or a payout over time based on the performance of Genzyme's experimental multiple sclerosis drug, Lemtrada, the sources said.

Ugh, the earnout survived! 



| Permalink

TrackBack URL for this entry:


Listed below are links to weblogs that reference Genzyme deal reached?:


Post a comment